130 related articles for article (PubMed ID: 15883202)
1. Molecular pharmacology of the interaction of anthracyclines with iron.
Xu X; Persson HL; Richardson DR
Mol Pharmacol; 2005 Aug; 68(2):261-71. PubMed ID: 15883202
[TBL] [Abstract][Full Text] [Related]
2. Cardiotoxicity of doxorubicin is mediated through mitochondrial iron accumulation.
Ichikawa Y; Ghanefar M; Bayeva M; Wu R; Khechaduri A; Naga Prasad SV; Mutharasan RK; Naik TJ; Ardehali H
J Clin Invest; 2014 Feb; 124(2):617-30. PubMed ID: 24382354
[TBL] [Abstract][Full Text] [Related]
3. Identification of the molecular basis of doxorubicin-induced cardiotoxicity.
Zhang S; Liu X; Bawa-Khalfe T; Lu LS; Lyu YL; Liu LF; Yeh ET
Nat Med; 2012 Nov; 18(11):1639-42. PubMed ID: 23104132
[TBL] [Abstract][Full Text] [Related]
4. Effects of doxorubicin-induced cardiotoxicity on cardiac mitochondrial dynamics and mitochondrial function: Insights for future interventions.
Osataphan N; Phrommintikul A; Chattipakorn SC; Chattipakorn N
J Cell Mol Med; 2020 Jun; 24(12):6534-6557. PubMed ID: 32336039
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial Determinants of Doxorubicin-Induced Cardiomyopathy.
Wallace KB; Sardão VA; Oliveira PJ
Circ Res; 2020 Mar; 126(7):926-941. PubMed ID: 32213135
[TBL] [Abstract][Full Text] [Related]
6. Topoisomerase IIbeta mediated DNA double-strand breaks: implications in doxorubicin cardiotoxicity and prevention by dexrazoxane.
Lyu YL; Kerrigan JE; Lin CP; Azarova AM; Tsai YC; Ban Y; Liu LF
Cancer Res; 2007 Sep; 67(18):8839-46. PubMed ID: 17875725
[TBL] [Abstract][Full Text] [Related]
7. Ferroptosis as a target for protection against cardiomyopathy.
Fang X; Wang H; Han D; Xie E; Yang X; Wei J; Gu S; Gao F; Zhu N; Yin X; Cheng Q; Zhang P; Dai W; Chen J; Yang F; Yang HT; Linkermann A; Gu W; Min J; Wang F
Proc Natl Acad Sci U S A; 2019 Feb; 116(7):2672-2680. PubMed ID: 30692261
[TBL] [Abstract][Full Text] [Related]
8. Molecular mechanism of doxorubicin-induced cardiomyopathy - An update.
Renu K; V G A; P B TP; Arunachalam S
Eur J Pharmacol; 2018 Jan; 818():241-253. PubMed ID: 29074412
[TBL] [Abstract][Full Text] [Related]
9. Regulated cell death pathways in doxorubicin-induced cardiotoxicity.
Christidi E; Brunham LR
Cell Death Dis; 2021 Apr; 12(4):339. PubMed ID: 33795647
[TBL] [Abstract][Full Text] [Related]
10. Oxidative Stress and Cellular Response to Doxorubicin: A Common Factor in the Complex Milieu of Anthracycline Cardiotoxicity.
Cappetta D; De Angelis A; Sapio L; Prezioso L; Illiano M; Quaini F; Rossi F; Berrino L; Naviglio S; Urbanek K
Oxid Med Cell Longev; 2017; 2017():1521020. PubMed ID: 29181122
[TBL] [Abstract][Full Text] [Related]
11. Doxorubicin Blocks Cardiomyocyte Autophagic Flux by Inhibiting Lysosome Acidification.
Li DL; Wang ZV; Ding G; Tan W; Luo X; Criollo A; Xie M; Jiang N; May H; Kyrychenko V; Schneider JW; Gillette TG; Hill JA
Circulation; 2016 Apr; 133(17):1668-87. PubMed ID: 26984939
[TBL] [Abstract][Full Text] [Related]
12. Doxorubicin-induced cardiomyopathy: from molecular mechanisms to therapeutic strategies.
Octavia Y; Tocchetti CG; Gabrielson KL; Janssens S; Crijns HJ; Moens AL
J Mol Cell Cardiol; 2012 Jun; 52(6):1213-25. PubMed ID: 22465037
[TBL] [Abstract][Full Text] [Related]
13. Anthracycline-induced cardiotoxicity: overview of studies examining the roles of oxidative stress and free cellular iron.
Simůnek T; Stérba M; Popelová O; Adamcová M; Hrdina R; Gersl V
Pharmacol Rep; 2009; 61(1):154-71. PubMed ID: 19307704
[TBL] [Abstract][Full Text] [Related]
14. Doxorubicin-induced cardiomyopathy from the cardiotoxic mechanisms to management.
Takemura G; Fujiwara H
Prog Cardiovasc Dis; 2007; 49(5):330-52. PubMed ID: 17329180
[TBL] [Abstract][Full Text] [Related]
15. Pyridoxamine Limits Cardiac Dysfunction in a Rat Model of Doxorubicin-Induced Cardiotoxicity.
Haesen S; Jager MM; Brillouet A; de Laat I; Vastmans L; Verghote E; Delaet A; D'Haese S; Hamad I; Kleinewietfeld M; Mebis J; Mullens W; Lambrichts I; Wolfs E; Deluyker D; Bito V
Antioxidants (Basel); 2024 Jan; 13(1):. PubMed ID: 38247537
[TBL] [Abstract][Full Text] [Related]
16. Chemical-induced phase transition and global conformational reorganization of chromatin.
Wang T; Shi S; Shi Y; Jiang P; Hu G; Ye Q; Shi Z; Yu K; Wang C; Fan G; Zhao S; Ma H; Chang ACY; Li Z; Bian Q; Lin CP
Nat Commun; 2023 Sep; 14(1):5556. PubMed ID: 37689690
[TBL] [Abstract][Full Text] [Related]
17. Targeting mitochondrial dynamics proteins for the treatment of doxorubicin-induced cardiotoxicity.
Chen R; Niu M; Hu X; He Y
Front Mol Biosci; 2023; 10():1241225. PubMed ID: 37602332
[TBL] [Abstract][Full Text] [Related]
18. The dual role of ferroptosis in anthracycline-based chemotherapy includes reducing resistance and increasing toxicity.
Zhao J; Zhang N; Ma X; Li M; Feng H
Cell Death Discov; 2023 Jun; 9(1):184. PubMed ID: 37344500
[TBL] [Abstract][Full Text] [Related]
19. An integrative review of nonobvious puzzles of cellular and molecular cardiooncology.
Uruski P; Matuszewska J; Leśniewska A; Rychlewski D; Niklas A; Mikuła-Pietrasik J; Tykarski A; Książek K
Cell Mol Biol Lett; 2023 May; 28(1):44. PubMed ID: 37221467
[TBL] [Abstract][Full Text] [Related]
20. New Insights into the Role of Ferroptosis in Cardiovascular Diseases.
Fratta Pasini AM; Stranieri C; Busti F; Di Leo EG; Girelli D; Cominacini L
Cells; 2023 Mar; 12(6):. PubMed ID: 36980208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
